31 research outputs found
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
Get PDF
Long-term follow-up of efficacy of irinotecan-based chemotherapy in poor-risk patients suffering from metastatic colorectal cancer.
No full textMale breast cancer: An analysis of clinical features, disease outcome and treatment efficacy
No full text
Effect of Modification of the Carboxyl Groups of the Sialic Acid Binding Lectin from Bullfrog (Rana catesbeiana) Oocyte on Anti-tumor Activity.
No full textRadioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network.
No full textLetter to the Edito
Radioimmunotherapy with Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT : an analysis of the international RIT-Network
No full textUse of radioimmunotherapy for consolidation for chemosensitive mantle cell lymphoma (MCL): Summary of International Radioimmunotherapy Registry data.
No full text
